Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Molecularly Tailored Therapy for Metastatic Pancreatic Cancer
NCT01888978Phase 2Completed
- Sponsor
- Georgetown University
- Start
- Dec 2012
- Primary completion
- Jun 2016
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, oxaliplatin, fluorouracil, docetaxel, irinotecan, sponsored by Georgetown University. Started Dec 2012; status: completed.
02
Drugs
gemcitabineoxaliplatinfluorouracildocetaxelirinotecan
Beyond the preview
Go deeper on NCT01888978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01888978.